Evidence map›Paper›PMID 33126454›Full record

ArticleVaccines2020

Value Frameworks for Vaccines: Which Dimensions Are Most Relevant?

Jeroen Luyten, Roselinde Kessels, Corinne Vandermeulen, Philippe Beutels

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Vaccines, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Article
  3. Public Preferences for Policies to Promote COVID-19 Vaccination Uptake: A Discrete Choice Experiment in The Netherlands.Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research · 2022
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Jeroen LuytenKU Leuven, Department of Public Health and Primary Care, Leuven Institute for Healthcare Policy, Kapucijnenvoer 35, PO 7001, 3000 Leuven, Belgium.ORCID 0000-0001-6398-4025
Roselinde KesselsDepartment of Data Analytics and Digitalization, Maastricht University, P.O. Box 616, 6200 MD Maastricht, The Netherlands.ORCID 0000-0002-4534-0047
Corinne VandermeulenKU Leuven, Department of Public Health and Primary Care, Leuven University Vaccinology Centre, Kapucijnenvoer 35, PO 7001, 3000 Leuven, Belgium.ORCID 0000-0002-1954-7554
Philippe BeutelsCentre for Health Economics Research and Modelling Infectious Diseases, Vaccine and Infectious Disease Institute, University of Antwerp, Universiteitsplein 1, 2610 Wilrijk, Belgium.

Funding

Flemish government - Agency of Health and Care NA
6 · The paper itself

Abstract

In addition to more narrow criteria such as safety, effectiveness and cost-effectiveness, vaccines can also be evaluated based on broader criteria such as their economic impact, contribution to disease eradication objectives, caregiver aspects, financial protection offered, equity or social acceptability. We summarize a survey executed in a sample of the population (

Indexed as

evaluation spacehealth technology assessmentpublic involvementpublic preferencesvaccine evaluation

Identifiers

PMID33126454
PMCPMC7712404

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.